| |
|
|
|
|
|
HIV, human immunodeficiency virus, is the virus that causes Acquired Immunodeficiency Syndrome (AIDS). The virus primarily infects cells of the immune system, T helper cells. Attachment occurs via the CD4 protein present in the T helper cell and over time, this leads to decline in the number of T helper cells, resulting in a decline in the person's immune system leads to a person's inability to fight infection.
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
Bio-Rad LaboratoriesEIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2 (HIV-1 and HIV-2) in human serum, plasma or cadaveric serum specimens.
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
PRIMACY Medical is supplied as standard with the normal adjustable end cap, as illustrated, for conventional blood sampling form the finger tips. Instructions for this method of sampling are provided with the device.
|
Company:
Date:
November 30, 2009
|
|
|
|
|
|
|
|
|
|
Reliable & clear visible results in short time.
|
Company:
Date:
April 26, 2010
|
|
|
|
|
|
|
|
|
|
Prognosis / Patient Management. HIV-1 Viral Load Assay. NucliSens HIV-1 QT covers the entire dynamic range of viral load testing from a single patient sample, without reflex testing or thermalcycling.
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
The OraQuick ADVANCE Rapid HIV-1/2 Antibody test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingerstick whole blood, venipuncture whole blood, and plasma specimens
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
Protecting ER staff by identifying HIV-positive patients prior to treatment .identifying exposure to HIV through accidental needle sticks ,Minimizing HIV transmission to the infant of an infected mother during childbirth.Ensuring that HIV-positive inmates are identified upon internment
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
The Reveal Rapid HIV-1 Antibody test (Reveal test) is MedMiras flagship rapid HIV test. This test detects antibodies in human serum or plasma against HIV-1 that are produced by the body in response to HIV infection. The Reveal test is based on MedMiras proprietary flow-through membrane technology, and is comprised of a single-use test cartridge containing an immunoreactive test membrane. The membrane functions to capture HIV-1 antibodies in serum or plasma when a drop of the specimen is applied. The test is manually performed and visually interpreted with the result available within 3 minutes.
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
The VERSANT® HIV-1 RNA 3.0 Assay (bDNA) delivers unmatched precision and reproducibility, so you can be confident that you're providing physicians with viral load values they can trust
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|
|
|
|
|
Vironostika HIV assays provide superior specificity, thereby reducing the need for additional testing and confirmation. Vironostika HIV-1 Microelisa System is an enzyme-linked immunosorbent assay for the detection of antibody to HIV-1 in serum, plasma or dried blood spots. Oral Fluid Vironostika HIV-1 Microelisa System is an enzyme-linked immuosorbent assay for the detection of antibody to HIV-1 in human oral fluid.
|
Company:
Date:
November 14, 2008
|
|
|
|
|
|